1. Home
  2. BMHL vs RCEL Comparison

BMHL vs RCEL Comparison

Compare BMHL & RCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BMHL

Bluemount Holdings Limited Class B Ordinary Shares

N/A

Current Price

$3.73

Market Cap

95.2M

Sector

N/A

ML Signal

N/A

Logo Avita Medical Inc.

RCEL

Avita Medical Inc.

HOLD

Current Price

$3.91

Market Cap

102.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BMHL
RCEL
Founded
2016
N/A
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
95.2M
102.5M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
BMHL
RCEL
Price
$3.73
$3.91
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$7.17
AVG Volume (30 Days)
5.0K
228.3K
Earning Date
01-30-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
9.50
N/A
EPS
0.05
N/A
Revenue
$6,873,097.00
$72,401,000.00
Revenue This Year
N/A
$13.12
Revenue Next Year
N/A
$27.56
P/E Ratio
$69.06
N/A
Revenue Growth
66.02
20.59
52 Week Low
$2.72
$3.22
52 Week High
$4.49
$11.25

Technical Indicators

Market Signals
Indicator
BMHL
RCEL
Relative Strength Index (RSI) N/A 66.13
Support Level N/A $3.24
Resistance Level N/A $3.57
Average True Range (ATR) 0.00 0.20
MACD 0.00 0.05
Stochastic Oscillator 0.00 95.83

Price Performance

Historical Comparison
BMHL
RCEL

About BMHL Bluemount Holdings Limited Class B Ordinary Shares

Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in rollout across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

Share on Social Networks: